Novo Nordisk buys experimental blood pressure drug from Singapore
Danish Novo Nordisk said on Monday 16 October 2023 that it will spend up to $1.3 billion to buy an experimental hypertension (high blood pressure) drug from Singapore-based ‘KBP Biosciences.’ …
Novo Nordisk buys experimental blood pressure drug from Singapore Read More